ERBB2 and neoplasm: In contrast, a tumor lacking a treatable domain, such as p95 HER2 tumors (Abraham et al., 2019; Pedersen et al., 2009; Scaltriti et al., 2007), is also the most unlikely to be detected and most likely to disseminate.